| Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities |
|
Clinical Lymphoma , Myeloma & Leukemia |
Myelodysplastic Syndromes (MDS) |
| How we diagnose Myelodysplastic syndromes |
|
Frontiers in Oncology |
Myelodysplastic Syndromes (MDS) |
| How I Treat Paroxysmal nocturnal hemoglobinuria |
|
Blood |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| How I Diagnose Low-Grade Myelodysplastic Syndromes |
|
American Journal of clinical Pathology |
Myelodysplastic Syndromes (MDS) |
| HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties |
|
American Journal of Hematology |
Aplastic Anemia |
| Higher-risk myelodysplastic syndromes with del(5q): does the del(5q) matter? |
|
Expert Review of Hematology |
Myelodysplastic Syndromes (MDS) |
| High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag |
|
Leukemia |
Aplastic Anemia |
| High Serum Ferritin Levels in Newly Diagnosed Patients With Myelodysplastic Syndromes Are Associated With Greater Symptom Severity |
|
International Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
| High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity |
|
International Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
| Heterogeneity in Health-Related Quality of Life of Patients with Aplastic Anemia: A Latent Profile Analysis |
|
Patient Preference and Adherence |
Aplastic Anemia |
